Acute XXXX after intravitreal injection of bevacizumab (avastin) associated with @entity63 .

@entity1 @entity1018 @entity64 @entity6 @entity63 @entity4 @entity1887 @entity1003 @entity941 @entity432 @entity543
AIM: To report a @entity1 with @entity6 who suffered from acute retinal ischemic change and @entity64 after intravitreal injection of bevacizumab. METHODS: A 55-year-old @entity1 had @entity6 with unilateral rubeosis and macular @entity4 . Three days after receiving intravitreal injection of bevacizumab (1.25 mg in 0.1 ml), he developed @entity1018 . A complete ocular examination, @entity941 angiography, carotid artery Doppler sonography and brain magnetic resonance imaging were performed. RESULTS: Best corrected visual acuity before injection was 6/60 in the left eye. He had underlying @entity543 combined with bilateral preproliferative @entity6 . Three days after intravitreal injection of bevacizumab, acute @entity63 occurred. He also suffered from @entity64 , and brain magnetic resonance angiography showed @entity432 . The final visual acuity was no light perception in the left eye and 3/6 in the right eye. CONCLUSIONS: @entity1 receiving intravitreal injections of bevacizumab should be evaluated for potential systemic risk factors such as @entity1887 , @entity1003 and poorly controlled @entity6 . Acute @entity63 change may be associated with intravitreal injection of bevacizumab in @entity1 with vascular compromised @entity6 and/or underlying stenosis of the carotid artery.
